187 related articles for article (PubMed ID: 22233400)
61. Ichthyosiform mycosis fungoides.
Badawy E; D'Incan M; El Majjaoui S; Franck F; Fabricio L; Dereure O; Souteyrand P; Guillot B
Eur J Dermatol; 2002; 12(6):594-6. PubMed ID: 12459538
[TBL] [Abstract][Full Text] [Related]
62. Comparison of pegylated interferon α-2b plus psoralen PUVA versus standard interferon α-2a plus PUVA in patients with cutaneous T-cell lymphoma.
Hüsken AC; Tsianakas A; Hensen P; Nashan D; Loquai C; Beissert S; Luger TA; Sunderkötter C; Schiller M
J Eur Acad Dermatol Venereol; 2012 Jan; 26(1):71-8. PubMed ID: 22168776
[TBL] [Abstract][Full Text] [Related]
63. Oral keratinocytes synthesize CTACK: A new insight into the pathophysiology of the oral mucosa.
Marshall A; Celentano A; Cirillo N; McCullough M; Porter S
Exp Dermatol; 2018 Feb; 27(2):207-210. PubMed ID: 29171092
[TBL] [Abstract][Full Text] [Related]
64. Treatment of mycosis fungoides with psoralen and long-wave ultraviolet light-A (PUVA).
Nozicková M; Simková M; Nozicka Z
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1987; 30(1):179-94. PubMed ID: 3481871
[No Abstract] [Full Text] [Related]
65. Interferon-based treatment for patients with mycosis fungoides and hepatitis C virus infection: a case series.
Kyvernitakis A; Duvic M; Mahale P; Torres HA
Am J Clin Dermatol; 2014 Oct; 15(5):451-6. PubMed ID: 24934807
[TBL] [Abstract][Full Text] [Related]
66. Narrowband UVB and PUVA in the treatment of mycosis fungoides: a retrospective study.
Ahmad K; Rogers S; McNicholas PD; Collins P
Acta Derm Venereol; 2007; 87(5):413-7. PubMed ID: 17721648
[TBL] [Abstract][Full Text] [Related]
67. Bath-water PUVA therapy with 8-methoxypsoralen in mycosis fungoides.
Weber F; Schmuth M; Sepp N; Fritsch P
Acta Derm Venereol; 2005; 85(4):329-32. PubMed ID: 16191854
[TBL] [Abstract][Full Text] [Related]
68. A case of advanced mycosis fungoides with comprehensive skin and visceral organs metastasis: sensitive to chemical and biological therapy.
Liu YQ; Zhu WY; Shu YQ; Gu YH
Asian Pac J Trop Med; 2012 Aug; 5(8):669-72. PubMed ID: 22840460
[TBL] [Abstract][Full Text] [Related]
69. Unusual variants of mycosis fungoides.
Abeldaño A; Arias M; Benedetti A; Ochoa K; Maskin M; Pellerano G; Kien MC; Chouela E
Skinmed; 2011; 9(4):218-22. PubMed ID: 21980706
[TBL] [Abstract][Full Text] [Related]
70. PUVA plus interferon α2b in the treatment of advanced or refractory to PUVA early stage mycosis fungoides: a case series.
Nikolaou V; Siakantaris MP; Vassilakopoulos TP; Papadavid E; Stratigos A; Economidi A; Marinos L; Papadaki T; Antoniou C
J Eur Acad Dermatol Venereol; 2011 Mar; 25(3):354-7. PubMed ID: 20586838
[TBL] [Abstract][Full Text] [Related]
71. Is PUVA maintenance therapy necessary in patients with early-stage mycosis fungoides? Evaluation of a treatment guideline over a 28-month follow-up.
Sánchez MA; González T; Gaitán MF; Zuluaga A; Jiménez SB; de Galvis YT
Int J Dermatol; 2011 Sep; 50(9):1086-93. PubMed ID: 21375528
[TBL] [Abstract][Full Text] [Related]
72. Interferon-alpha (INF-alpha) and etretinate in the treatment of mycosis fungoides.
Torii H; Kaneko T; Matsuyama T; Nakanishi H; Harada S
J Dermatol; 1994 Oct; 21(10):767-70. PubMed ID: 7798436
[TBL] [Abstract][Full Text] [Related]
73. The influence of psoralen + ultraviolet A treatment on the duration of remission and prognosis in mycosis fungoides.
Oguz O; Engin B; Aydemir EH
J Eur Acad Dermatol Venereol; 2003 Jul; 17(4):483-5. PubMed ID: 12834475
[No Abstract] [Full Text] [Related]
74. A randomized cross-over study to compare PUVA and extracorporeal photopheresis in the treatment of plaque stage (T2) mycosis fungoides.
Child FJ; Mitchell TJ; Whittaker SJ; Scarisbrick JJ; Seed PT; Russell-Jones R
Clin Exp Dermatol; 2004 May; 29(3):231-6. PubMed ID: 15115499
[TBL] [Abstract][Full Text] [Related]
75. Palliative local radiotherapy in the treatment of tumor-stage cutaneous T-cell lymphoma/mycosis fungoides.
Xu CC; Zhang T; Wang T; Liu J; Liu YH
Chin Med Sci J; 2014 Mar; 29(1):33-7. PubMed ID: 24698676
[TBL] [Abstract][Full Text] [Related]
76. Methoxsalen photochemotherapy for mycosis fungoides.
Gilchrest BA
Cancer Treat Rep; 1979 Apr; 63(4):663-7. PubMed ID: 445518
[TBL] [Abstract][Full Text] [Related]
77. Chemokines in onchocerciasis patients after a single dose of ivermectin.
Fendt J; Hamm DM; Banla M; Schulz-Key H; Wolf H; Helling-Giese G; Heuschkel C; Soboslay PT
Clin Exp Immunol; 2005 Nov; 142(2):318-26. PubMed ID: 16232219
[TBL] [Abstract][Full Text] [Related]
78. Poikilodermatous Mycosis Fungoides - Rare Entity, Different Treatment Modalities.
Jerković Gulin S; Čeović R; Ilić I; Bradamante M; Bukvić Mokos Z; Kostović K
Acta Dermatovenerol Croat; 2018 Apr; 26(1):48-52. PubMed ID: 29782300
[TBL] [Abstract][Full Text] [Related]
79. Retinoids plus PUVA (RePUVA) and PUVA in mycosis fungoides, plaque stage. A report from the Scandinavian Mycosis Fungoides Group.
Thomsen K; Hammar H; Molin L; Volden G
Acta Derm Venereol; 1989; 69(6):536-8. PubMed ID: 2575334
[TBL] [Abstract][Full Text] [Related]
80. Interferon-alpha is effective for CD4(+), CCR4(-) mycosis fungoides.
Fujimura T; Okuyama R; Watabe A; Hashimoto A; Tagami H; Aiba S
Int J Dermatol; 2007 Apr; 46(4):435-8. PubMed ID: 17442093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
